V Rodriguez

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Diffuse large B-cell lymphoma in an adolescent female presenting with Epstein-Barr virus-driven hemophagocytic lymphohistiocytosis: a case report
    Sadaf Altaf
    Division of Pediatric Hematology Oncology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
    J Med Case Rep 6:141. 2012
  2. pmc Empiric treatment of protracted idiopathic purpura fulminans in an infant: a case report and review of the literature
    Fima Macheret
    Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA
    J Med Case Reports 5:201. 2011
  3. doi request reprint Central venous access devices for paediatric patients with haemophilia: a single-institution experience
    R Titapiwatanakun
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota, USA
    Haemophilia 15:168-74. 2009
  4. ncbi request reprint Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia
    Vilmarie Rodriguez
    Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Leuk Lymphoma 47:1583-92. 2006
  5. doi request reprint Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience
    Vilmarie Rodriguez
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN55905, USA
    J Pediatr Hematol Oncol 31:522-6. 2009
  6. ncbi request reprint Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut
    Vilmarie Rodriguez
    Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Pediatr Blood Cancer 49:212-5. 2007
  7. doi request reprint To circumcise or not to circumcise? Circumcision in patients with bleeding disorders
    V Rodriguez
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Haemophilia 16:272-6. 2010
  8. ncbi request reprint Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus
    Vilmarie Rodriguez
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN 55905, USA
    J Pediatr Hematol Oncol 27:403-7. 2005
  9. ncbi request reprint Low toxicity and efficacy of (153)samarium-EDTMP and melphalan as a conditioning regimen for secondary acute myelogenous leukemia
    Vilmarie Rodriguez
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Pediatr Transplant 9:122-6. 2005
  10. doi request reprint Hemostatic management of an infant with severe hemophilia A and tetralogy of Fallot for cardiac bypass surgery
    Vilmarie Rodriguez
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Pediatr Blood Cancer 55:1399-401. 2010

Collaborators

Detail Information

Publications25

  1. pmc Diffuse large B-cell lymphoma in an adolescent female presenting with Epstein-Barr virus-driven hemophagocytic lymphohistiocytosis: a case report
    Sadaf Altaf
    Division of Pediatric Hematology Oncology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
    J Med Case Rep 6:141. 2012
    ..abstract:..
  2. pmc Empiric treatment of protracted idiopathic purpura fulminans in an infant: a case report and review of the literature
    Fima Macheret
    Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA
    J Med Case Reports 5:201. 2011
    ..abstract:..
  3. doi request reprint Central venous access devices for paediatric patients with haemophilia: a single-institution experience
    R Titapiwatanakun
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota, USA
    Haemophilia 15:168-74. 2009
    ..The low rate of clinically apparent thrombosis reflects our practice of not screening for thrombosis. The low infection rate reflects our practice of using and reinforcing the aseptic technique...
  4. ncbi request reprint Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia
    Vilmarie Rodriguez
    Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Leuk Lymphoma 47:1583-92. 2006
    ..Thus, in adolescents and adults, 153Sm-EDTMP may provide a relatively simple and effective means for using irradiation to eliminate AML within the marrow...
  5. doi request reprint Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience
    Vilmarie Rodriguez
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN55905, USA
    J Pediatr Hematol Oncol 31:522-6. 2009
    ..quot; The hematologic features of KMP and those of chronic coagulopathy seen with other vascular malformations can be similar, which makes KMP difficult to distinguish...
  6. ncbi request reprint Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut
    Vilmarie Rodriguez
    Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Pediatr Blood Cancer 49:212-5. 2007
    ..In case 2, corticosteroid-unresponsive grade 3 acute liver and gut GVHD developed on day +37. In both patients, GVHD responded to the infliximab-daclizumab regimen without toxicity and immunosuppressive therapy was discontinued...
  7. doi request reprint To circumcise or not to circumcise? Circumcision in patients with bleeding disorders
    V Rodriguez
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Haemophilia 16:272-6. 2010
    ..Some of our patients had significant bleeding despite adequate factor replacement before and after the procedure. Parents and patients must be aware that bleeding risk is a possibility despite adequate factor replacement for hemostasis...
  8. ncbi request reprint Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus
    Vilmarie Rodriguez
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN 55905, USA
    J Pediatr Hematol Oncol 27:403-7. 2005
    ....
  9. ncbi request reprint Low toxicity and efficacy of (153)samarium-EDTMP and melphalan as a conditioning regimen for secondary acute myelogenous leukemia
    Vilmarie Rodriguez
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Pediatr Transplant 9:122-6. 2005
    ..She achieved engraftment on day +23. Three years after transplantation, she continues to have complete remission. Samarium and melphalan constitute a well-tolerated regimen with potential antileukemic activity...
  10. doi request reprint Hemostatic management of an infant with severe hemophilia A and tetralogy of Fallot for cardiac bypass surgery
    Vilmarie Rodriguez
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Pediatr Blood Cancer 55:1399-401. 2010
    ..Although cardiac surgery is successful, exposure to factor concentrates in severe hemophilia early in life might predispose a patient to inhibitor development...
  11. ncbi request reprint Haemorrhage into a popliteal cyst: an unusual complication of haemophilia A
    V Rodriguez
    Comprehensive Hemophilia Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    Haemophilia 8:725-8. 2002
    ..Imaging studies showed that by day 10 a popliteal cyst had ruptured, with diffusion of blood into the calf muscles. This case illustrates another possible bleeding complication in patients with a bleeding disorder and a popliteal cyst...
  12. ncbi request reprint Intracranial haemorrhage as initial presentation of severe haemophilia B: case report and review of Mayo Clinic Comprehensive Hemophilia Center experience
    V Rodriguez
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN, USA
    Haemophilia 11:73-7. 2005
    ..His family history was negative for haemophilia. Review of our institutional experience as well as the literature indicates that intracranial bleeding as the initial presentation of haemophilia is rare...
  13. ncbi request reprint Wilms' tumor and neuroblastoma
    B Z Morgenstern
    Department of Pediatric and Adolescent Medicine, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    Acta Paediatr Suppl 93:78-84; discussion 84-5. 2004
    ..It is anticipated that the unification of the North American groups will lead to greater interest and scientific cooperation with the European study group. This paper will serve as a forum for such a discussion at a local level...
  14. doi request reprint Tacrolimus with mini-methotrexate as prophylaxis for graft-versus-host disease in pediatric patients after allogeneic peripheral blood stem cell transplant or bone marrow transplant
    Christine Sabapathy
    Division of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Pediatr Hematol Oncol 30:945-9. 2008
    ..One patient had extensive chronic GVHD (matched sibling transplant). In our experience, tacrolimus with mini-methotrexate has been well tolerated with minimal toxicity...
  15. ncbi request reprint Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G)
    Rajiv K Pruthi
    Special Coagulation Laboratory, Mayo Clinic, Rochester, MN 55905, USA
    Eur J Haematol 79:354-9. 2007
    ..This mutation in the heterozygous form was also present in a mildly affected, unrelated patient. We also report on the natural history of an FVII inhibitor in the patient with severe FVII deficiency...
  16. ncbi request reprint Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report
    Mark E Wylam
    Department of Pediatrics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Pediatr 143:674-7. 2003
    ..After initiation of anti-CD20 therapy, clinical improvement (muscular strength, pulmonary function) was observed...
  17. ncbi request reprint Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis
    H Imran
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Bone Marrow Transplant 37:677-86. 2006
    ..However, a large randomized controlled trial is needed for confirmation. Additionally, in future studies, owing to the wide spectrum of severity of veno-occlusive disease, outcomes such as 100-day mortality should strongly be considered...
  18. doi request reprint Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome
    Amulya A Nageswara Rao
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Pediatr Blood Cancer 52:536-8. 2009
    ..We describe the use of rituximab in the successful initial management of a probable case of pediatric CAPS...
  19. doi request reprint Bacterial endocarditis and septic arthritis in a patient with severe hemophilia A: a case report
    Ruetima Titapiwatanakun
    Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN 55905, USA
    J Pediatr Hematol Oncol 31:344-5. 2009
    ..Endocarditis and septic arthritis in patients with hemophilia are rare infectious complications but should be considered in patients with persistent bacteremia...
  20. ncbi request reprint Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia
    V Rodriguez
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Transplant Proc 34:1307-9. 2002
  21. doi request reprint Transient neonatal acquired von Willebrand syndrome due to transplacental transfer of maternal monoclonal antibodies
    Amulya A Nageswara Rao
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Pediatr Blood Cancer 53:655-7. 2009
    ....
  22. doi request reprint Novel splice site mutations in the gamma glutamyl carboxylase gene in a child with congenital combined deficiency of the vitamin K-dependent coagulation factors (VKCFD)
    Ruetima Titapiwatanakun
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Pediatr Blood Cancer 53:92-5. 2009
    ..Oral vitamin K supplementation resulted in partial resolution of proteins and complete resolution of bleeding...
  23. doi request reprint Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma
    Jonathan S C Caudill
    Divisions of Pediatric Hematology Oncology, Hematology, Hematopathology, and Transfusion Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Transfusion 49:765-70. 2009
    ..Quantitative differences in pFXIII concentration in FFP and cryoprecipitate are not well defined and were, therefore, the subject of this study...
  24. ncbi request reprint Sebastian platelet syndrome: a hereditary macrothrombocytopenia
    Vilmarie Rodriguez
    Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 78:1416-21. 2003
    ..The differential diagnosis of hereditary thrombocytopenias is reviewed briefly...
  25. ncbi request reprint Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma
    Peter M Anderson
    Pediatrics Unit, M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Clin Cancer Res 11:6895-900. 2005
    ..The strategy of radioactive drug binding to a target followed by a radiosensitizer may provide synergy and improved response rate...